CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-January
2024-October

ASC Fee Schedule

2025-January
2024-October

APC Codes

2025-January
2024-October

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-January
2024-October


CMS Transmittals



.


FRIDAY COMPLIANCE BRIEFING: 8/16/2002

EDITOR'S WELCOME

This week begins a series of briefings based on the Center for Medicare and Medicaid Services (CMS) July 31 Program Memorandum (PM) on Advance Beneficiary Notices (ABNs). This lengthy PM discusses in detail the many requirements regarding ABNs for labs and other providers and how to use the new "official" ABN forms; CMS-R-131-G for general use, and CMS-R-131-L for laboratory use. This week's briefing discusses the question of whether frequent use of ABNs can signal a violation of the HIPAA prohibitions regarding medically unnecessary claims. As always, please feel free to forward questions, concerns, or ideas for future Friday Compliance Briefings.

Sincerely,

Charles B. Root, Ph.D.

HEALTH INSURANCE PORTABILITY & ACCOUNTABILITY ACT OF 1996 (HIPAA) AND THE USE OF ABNs

Section 231(e)(4) of HIPAA provides for significant penalties when providers submit claims that represent "a pattern of medical or other items or services that a person knows or should know are not medically ne....

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.